| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |